Bağımlılığın Epidemiyolojisi: Madde Kullanım Örüntüleri, Risk Grupları ve Küresel Yük
References
Academy of Consultation-Liaison Psychiatry. Addiction. Journal Article Annotations 2025, 1st Quarter. 2025. Available from: https://clpsychiatry.org/annotated-abstracts/2025-q1/addiction/ [Accessed: 03 September 2026].
United Nations Office on Drugs and Crime (UNODC). World Drug Report 2026. Vienna: United Nations Publication; 2026. Available from: https://www.unodc.org/unodc/en/press/releases/2026/June/unodc-world-drug-report-2026_-global-drug-markets-transforming-rapidly-as-technology--novel-drug-types-and-instability-present-traffickers-with-new-opportunities.html [Accessed: 05 September 2026].
KFF (Kaiser Family Foundation). Opioid Overdose Deaths: National Trends and Variation by Demographics and States. 2025. Available from: https://www.kff.org/mental-health/opioid-overdose-deaths-national-trends-and-variation-by-demographics-and-states/ [Accessed: 03 September 2026].
United Nations Office on Drugs and Crime (UNODC). World Drug Report 2025. Vienna: United Nations Publication; 2025. Available from: https://www.unodc.org/unodc/en/press/releases/2025/June/unodc-world-drug-report-2025_-global-instability-compounding-social--economic-and-security-costs-of-the-world-drug-problem.html [Accessed: 03 September 2026].
World Health Organization (WHO). Global status report on alcohol and health and treatment of substance use disorders. Geneva: WHO; 2024. Available from: https://www.who.int/news/item/25-06-2024-over-3-million-annual-deaths-due-to-alcohol-and-drug-use-majority-among-men [Accessed: 03 September 2026].
World Health Organization (WHO). WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030. Geneva: WHO; 2025. Available from: https://www.who.int/europe/news/item/08-10-2025-who-european-region-has-the-highest-rate-of-tobacco-use-in-the-world--with-an-alarming-rise-in-young-people-using-e-cigarettes--global-report-warns [Accessed: 03 September 2026].
Avcı M. Adolescents' experiences with substance use: risks, protective factors and interventions. BMC Psychology. 2025;13(1): 802. doi:10.1186/s40359-025-03125-w
Chen D, Sun Y, Li X, Yin Z. Global burden on drug use disorders from 1990 to 2021 and projections to 2046. Frontiers in Public Health. 2025;13: 1550518. doi:10.3389/fpubh.2025.1550518
Towers EB, Williams IL, Qillawala EI, Rissman EF, Lynch WJ. Sex/gender differences in the time-course for the development of substance use disorder: a focus on the telescoping effect. Pharmacological Reviews. 2023;75(2): 217–249. doi:10.1124/pharmrev.121.000361
Centers for Disease Control and Prevention (CDC). Adverse Childhood Experiences and Health Conditions and Risk Behaviors Among High School Students — Youth Risk Behavior Survey, United States, 2023. MMWR Supplements. 2024. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559682/ [Accessed: 03 September 2026].
Baranyi G, Fazel S, Langerfeldt SD, Mundt AP. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis. Lancet Public Health. 2022;7(6): e557–e568. doi:10.1016/S2468-2667(22)00093-7
Zhu DT, Kwon YIC, Lai A, Park AMG, Barnes AJ, Chapman DA. Global burden of disease due to opioid, amphetamine, cocaine, and cannabis use disorders, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. PLOS ONE. 2025;20(8): e0328276. doi:10.1371/journal.pone.0328276
Ghimire R, Florence C, Guy G. Productivity losses from substance use disorder in the U.S. in 2023. American Journal of Preventive Medicine. 2026;70(2): 108102. doi:10.1016/j.amepre.2025.108102
American Medical Association (AMA). Time for decisive action on substance-use disorder treatment. 2025. Available from: https://www.ama-assn.org/public-health/behavioral-health/time-decisive-action-substance-use-disorder-treatment [Accessed: 03 September 2026].
Paul KK, Frey CG, Troung S, et al. Buprenorphine-Naloxone for Opioid Use Disorder: Reduction in Mortality and Increased Remission. Western Journal of Emergency Medicine. 2024. doi:10.5811/westjem.18569
Agrawal A, Verweij KJH, Gillespie NA, et al. The genetics of addiction—a translational perspective. Translational Psychiatry. 2012;2: e140. doi:10.1038/tp.2012.54
Kar P, Tomfohr-Madsen L, Giesbrecht G, et al. Alcohol and substance use in pregnancy during the COVID-19 pandemic. Drug and Alcohol Dependence. 2021;225: 108760. doi:10.1016/j.drugalcdep.2021.108760
Roberts A, Rogers J, Mason R, et al. Alcohol and other substance use during the COVID-19 pandemic: a systematic review. Drug and Alcohol Dependence. 2021;229: 109150. doi:10.1016/j.drugalcdep.2021.109150
Emniyet Genel Müdürlüğü Narkotik Suçlarla Mücadele Daire Başkanlığı. Türkiye Uyuşturucu Raporu 2025 (2024 Verileri): Eğilimler ve Gelişmeler. Ankara: Emniyet Genel Müdürlüğü; 2025. Available from: https://www.narkotik.pol.tr/kurumlar/narkotik.pol.tr/Duyurular/2025/10/2025-Uyusturucu-Raporu.pdf [Accessed: 05 September 2026].
Sunderland M, Vescovi J, Chapman C, Arya V, Harris M, Burgess P, Marel C, Mills K, Baillie A, Teesson M, Slade T. Co-occurring mental and substance use disorders in Australia 2020–2022: prevalence, patterns, conditional probabilities and correlates in the general population. Australian and New Zealand Journal of Psychiatry. 2025;59(6): 522–532. doi:10.1177/00048674241284913
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.
World Health Organization (WHO). International Classification of Diseases, Eleventh Revision (ICD-11). Geneva: WHO; 2024. Available from: https://icd.who.int/en [Accessed: 05 September 2026].